Biotech Analysts, along with cardio-metabolic experts, discuss the evolving drug development landscape of obesity and NAFLD/NASH therapeutics (relevant companies KRO, ALT, AMGN, ARWR, AZN, ETNB, GPCR, IVA, LLY, MDGL, MRK, NVO, NVS, PFE, TERN, VKTX, ZEAL) on an Analyst/Industry conference call to be held on July 10 at 3 pm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KRO:
